Merck & Company Inc

NYSE:MRK USA Drug Manufacturers - General
Market Cap
$286.50 Billion
Market Cap Rank
#47 Global
#36 in USA
Share Price
$115.43
Change (1 day)
-0.16%
52-Week Range
$73.47 - $123.93
All Time High
$132.08
About

Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also pr… Read more

Merck & Company Inc (MRK) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.151x

Based on the latest financial reports, Merck & Company Inc (MRK) has a cash flow conversion efficiency ratio of 0.151x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($7.82 Billion) by net assets ($51.91 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Merck & Company Inc - Cash Flow Conversion Efficiency Trend (1989–2024)

This chart illustrates how Merck & Company Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Merck & Company Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Merck & Company Inc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Merck & Company Inc (1989–2024)

The table below shows the annual cash flow conversion efficiency of Merck & Company Inc from 1989 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $46.37 Billion $21.47 Billion 0.463x +33.96%
2023-12-31 $37.63 Billion $13.01 Billion 0.346x -16.64%
2022-12-31 $46.06 Billion $19.09 Billion 0.415x +12.42%
2021-12-31 $38.26 Billion $14.11 Billion 0.369x -8.62%
2020-12-31 $25.40 Billion $10.25 Billion 0.404x -21.92%
2019-12-31 $26.00 Billion $13.44 Billion 0.517x +27.22%
2018-12-31 $26.88 Billion $10.92 Billion 0.406x +117.86%
2017-12-31 $34.57 Billion $6.45 Billion 0.186x -27.55%
2016-12-31 $40.31 Billion $10.38 Billion 0.257x -7.22%
2015-12-31 $44.77 Billion $12.42 Billion 0.277x +72.23%
2014-12-31 $48.79 Billion $7.86 Billion 0.161x -27.67%
2013-12-31 $52.33 Billion $11.65 Billion 0.223x +23.26%
2012-12-31 $55.46 Billion $10.02 Billion 0.181x -16.91%
2011-12-31 $56.94 Billion $12.38 Billion 0.217x +14.15%
2010-12-31 $56.80 Billion $10.82 Billion 0.191x +245.33%
2009-12-31 $61.48 Billion $3.39 Billion 0.055x -82.23%
2008-12-31 $21.17 Billion $6.57 Billion 0.310x -8.66%
2007-12-31 $20.59 Billion $7.00 Billion 0.340x +0.32%
2006-12-31 $19.97 Billion $6.77 Billion 0.339x -9.22%
2005-12-31 $20.38 Billion $7.61 Billion 0.373x -16.46%
2004-12-31 $19.70 Billion $8.80 Billion 0.447x -11.70%
2003-12-31 $19.49 Billion $9.86 Billion 0.506x +22.82%
2002-12-31 $23.13 Billion $9.53 Billion 0.412x -5.23%
2001-12-31 $20.89 Billion $9.08 Billion 0.435x +12.27%
2000-12-31 $19.85 Billion $7.69 Billion 0.387x +5.49%
1999-12-31 $16.70 Billion $6.13 Billion 0.367x +13.71%
1998-12-31 $16.51 Billion $5.33 Billion 0.323x -29.68%
1997-12-31 $13.76 Billion $6.32 Billion 0.459x +20.77%
1996-12-31 $14.28 Billion $5.43 Billion 0.380x +81.01%
1995-12-31 $14.02 Billion $2.94 Billion 0.210x -37.37%
1994-12-31 $12.35 Billion $4.14 Billion 0.335x +22.80%
1993-12-31 $11.17 Billion $3.05 Billion 0.273x -38.63%
1992-12-31 $5.63 Billion $2.50 Billion 0.445x +0.71%
1991-12-31 $5.51 Billion $2.43 Billion 0.442x -5.81%
1990-12-31 $4.38 Billion $2.06 Billion 0.469x +36.89%
1989-12-31 $4.03 Billion $1.38 Billion 0.343x --